Announced Tue, 29 Sept, 2026 · 13:09 IST

Coral Laboratories 44th AGM: 6 resolutions passed, final dividend declared

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹546.25

prior close

₹547.55

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-1.3% vs market

Pharmaceuticals peers, median of 173sector+0.5%-0.7% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2+1.0-1.3+0.5-0.7

Next day

+4.0+0.8+3.2-0.4+4.4

+4.2-0.5+4.7-1.4+5.5

+4.3-0.5+4.8-1.6+5.9

+2.0+0.8+1.2-1.1+3.0

+3.0+0.5+2.4-1.2+4.2

+5.3-2.0+7.2-3.3+8.6

15d

-8.3-6.4-1.9-7.2-1.1

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Coral Laboratories held its 44th AGM on September 29, 2026, via video conferencing. Six resolutions were passed, including adoption of audited FY26 financial statements, declaration of final dividend, re-appointment of two directors retiring by rotation (Sushma Kadkade and Rajendrasinh Rana), ratification of cost auditor remuneration for FY27, and approval of remuneration to Non-Executive Director Sushma Kadkade. The meeting lasted 9 minutes with 20 members present. Audit reports had no qualifications. Voting results to be announced within 48 hours.

Likely market impact

Shareholders approved key items including final dividend and director re-appointments. Voting results awaited; routine procedural filing with no major surprises.